Amgen wins patent appeal on psoriasis drug Otzela against Zydus Pharma (USA), Sandoz Ruchika Sharma22 April 2023 1:30 PM ISTThousand Oaks: Amgen has announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District...
Sandoz gets European Commission nod for Hyrimoz high-concentration formulation Ruchika Sharma4 April 2023 2:00 PM ISTAdalimumab is a human immunoglobulin G1 (IgG(1)) monoclonal antibody targeting tumor necrosis factor alpha (TNF-a).
USFDA nod to citrate free high concentration formulation of biosimilar Hyrimoz injection: Sandoz Ruchika Sharma22 March 2023 1:45 PM ISTSandoz intends to launch the Hyrimoz citrate-free HCF in the US on July 1, 2023.
Novartis names Gilbert Ghostine as Chairman designate of Sandoz Board of Directors Ruchika Sharma20 Feb 2023 3:30 PM ISTGhostine is an experienced business leader with a track record of growing and transforming businesses in competitive industries.
USFDA accepts Biologics License Application for proposed biosimilar denosumab: Sandoz Ruchika Sharma7 Feb 2023 10:15 AM ISTDenosumab is a human monoclonal antibody designed to bind to the RANKL protein, an activator of osteoclasts (cells involved in breaking down bone...
Novartis division Sandoz to set up Global Capability Centre in Hyderabad MD Bureau1 Feb 2023 1:30 PM ISTThe centre will initially have a workforce of 800 employees, with plans to increase to approximately 1,800 people in the near future.
Operating profit to grow again ahead of Sandoz spin off: Novartis Ruchika Sharma1 Feb 2023 10:00 AM ISTNovartis said in its statement it's on track to spin off its generics unit Sandoz in the second half of the year as part of its effort to sharpen its...
Sandoz signs agreement to acquire antifungal agent Mycamine from Astellas Ruchika Sharma26 Jan 2023 11:30 AM ISTBasel: Sandoz has signed an agreement to acquire worldwide product rights for systemic antifungal agent Mycamine (micafungin sodium, Funguard in...
Patent infringement: Roche loses US appeal in Sandoz lung disease drug case Ruchika Sharma24 Dec 2022 11:30 AM ISTSan Francisco-based Genentech's Esbriet is used to treat IPF, a serious chronic lung disease. Roche earned over $1 billion last year from worldwide...
CDSCO tells Sandoz to review and report PSUR data of Brolucizumab injection Dr. Divya Colin27 Nov 2022 1:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has recommended the drug maker...
Sandoz, Teva Pharma plans to ramp up biosimilars production Ruchika Sharma23 Nov 2022 1:30 PM ISTTeva Chief Executive KÃ¥re Schultz said the company was targeting "80% of what's going off-patent in the next 10 years" including big sellers like the...
Former Sandoz Chief Richard Francis joins Teva Pharma as President, CEO Ruchika Sharma22 Nov 2022 1:30 PM ISTPrior to his role at Sandoz, Mr. Francis was a senior executive at Biogen for 13 years where he held a number of senior roles, including leading the...
